BAP1 and neoplasm: A moderate separation based on metabolite patterns is seen between the three molecular subclasses (Figure 2A), which is more profound in the PLS-DA comparing only the metabolite patterns of patients harboring a BAP1 or EIF1AX-mutated tumor (Figure 2B).